AmpliTech Group cuts Titan Crest price to $7M, targets FY27 EBITDA

2 min read     Updated on 17 Aug 2026, 07:07 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

AmpliTech Group reduces Titan Crest acquisition cost to $7M while maintaining $17M backlog. Zero debt supports operations as company targets positive EBITDA in FY27 via margin improvements from scaled ORAN production.

powered bylight_fuzz_icon
48519451

*this image is generated using AI for illustrative purposes only.

AmpliTech Group, Inc. (NASDAQ: AMPG) has revised the economics of its asset acquisition from Titan Crest, LLC, reducing the aggregate purchase price by $1 million to $7 million. Simultaneously, the company highlighted a robust balance sheet position with zero long-term debt supporting approximately $17 million in current order backlog.

The amendment to the Asset Purchase Agreement preserves AmpliTech’s rights and claims against Titan or its affiliates arising before the change. Titan’s affiliate assumed substantially all remaining covenants and indemnification obligations under the agreement.

Financial Outlook and Margin Expansion

Management projects full-year 2026 revenue to exceed FY25 levels, though precise estimates are withheld due to timing variability in customer deployments. Certain Asian customers have shifted previously anticipated deployment schedules, affecting shipment timing but not cancelling orders. Additional shipments are expected during the second half of 2026, with a portion potentially extending into 2027.

The company outlines a path to profitability driven by margin expansion. During its initial North American MNO program, AmpliTech strategically accepted approximately $2 million in reduced profit to establish technology with a major carrier and complete commercial qualification. With this market-entry phase substantially completed, management expects future ORAN orders to carry improved economics as production scales and supply-chain efficiencies improve.

Consequently, the company currently expects to achieve positive EBITDA in Fiscal Year 2027.

What the Numbers Show

The divergence between historical margin suppression and future guidance highlights a strategic pivot from market entry to commercial scaling. The explicit acknowledgment of $2 million in accepted reduced profit during the initial phase contextualizes prior operating losses as deliberate investment rather than operational inefficiency. This aligns with the expectation that future orders will carry higher margins, suggesting that the path to positive EBITDA in 2027 is dependent on volume growth rather than cost-cutting alone.

Operational Highlights and Market Position

AmpliTech reports over $17 million in 5G ORAN-related shipments since program inception, including more than 2,000 radios shipped and in service with a Tier-1 MNO. The portfolio holds FCC and ISED Canada certifications, including a newly certified AI-ready 4T8R macro radio and small cells product line.

Metric Value
Titan Crest Purchase Price $7 million
Current Order Backlog $17 million
ORAN Shipments Since Inception Over $17 million
Long-Term Debt Zero
Radios Shipped/In Service More than 2,000

The company is actively responding to a request for proposal from a Tier-1 telecommunications infrastructure equipment provider. Management believes this opportunity could represent tens of millions of dollars in aggregate value if awarded in full, though no assurance of award exists. Additional discussions are ongoing with mobile network operators and systems integrators in North America and international markets.

Capital is being deployed toward engineering, R&D, supply-chain capabilities, and personnel required to support larger telecommunications customers. A share repurchase authorization remains part of the capital allocation strategy, with timing subject to market conditions and liquidity.

How might the shift in deployment schedules by Asian customers impact AmpliTech's cash flow management and working capital requirements in the near term?

What specific supply-chain efficiencies or production scaling milestones must be achieved to validate the projected margin expansion for future ORAN orders?

Given the zero long-term debt position, how likely is it that AmpliTech will execute its share repurchase authorization before achieving positive EBITDA in FY2027?

like15
dislike

AmpliTech Q2 loss widens to $3.09m as heavy R&D spending offsets revenue beat

3 min read     Updated on 14 Aug 2026, 06:14 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

AmpliTech Group reported a Q2 2026 net loss of $3.09 million, wider than expected, due to doubled R&D spending on 5G and MMIC technologies. Revenue beat estimates at $8.07 million, driving a 161.2% YoY surge in gross profit to $2.25 million. The company strengthened its balance sheet with $20.12 million in net proceeds from a rights exercise and authorized a $10 million buyback program.

powered bylight_fuzz_icon
48208830

*this image is generated using AI for illustrative purposes only.

AmpliTech Group Inc. (NASDAQ: AMPG) shares fell sharply in premarket trading after the company reported a wider-than-expected second-quarter 2026 net loss, despite posting revenue that exceeded analyst consensus. The company recorded a net loss of $3.09 million, or 12 cents per share, compared to an expected loss of 2 cents per share. This deterioration in profitability contrasts with top-line performance, where sales reached $8.07 million, beating the $8.00 million estimate and rising 50.9% sequentially from $5.35 million in the first quarter.

The widening loss was primarily attributed to aggressive investments in product development and commercialization efforts. Research and development (R&D) expenses more than doubled to $1.37 million from $0.66 million in the prior-year quarter. This increase included approximately $1.08 million dedicated to 5G product development and prototype testing, alongside $0.30 million for monolithic microwave integrated circuit (MMIC) design. Selling, general, and administrative (SG&A) expenses also contributed to the bottom-line pressure, covering costs such as amortization, legal fees, stock-based compensation, and marketing.

Operational Efficiency Gains

Despite the expanded net loss, AmpliTech demonstrated significant improvement in gross profitability. Gross profit jumped 161.2 percent year-over-year to $2.25 million, up from $0.86 million in the second quarter of 2025. Consequently, the gross margin expanded to 27.9 percent, a substantial increase from 7.8 percent in the same period last year. Management noted that while this margin is lower than the 48.0 percent achieved in Q1 2026, the variance reflects changes in product and shipment mix.

Revenue growth was broad-based across the company’s four principal end markets: 5G/telecommunications infrastructure, SATCOM and space applications, defense and aerospace communications, and semiconductor and quantum computing applications. Sales in the amplifier and related passive microwave components and subsystems business grew 42.7% year-over-year. The company highlighted new O-RAN 5G product sales and expansion in its Spectrum Semiconductor Materials distribution business as key monetization drivers.

Balance Sheet and Liquidity

As of June 30, 2026, AmpliTech maintained a strong liquidity position with cash, cash equivalents, and marketable securities totaling approximately $12.95 million. Working capital stood at approximately $22.93 million, up from $10.16 million at the end of 2025, resulting in a current ratio of approximately 3.76. Total assets were reported at $58.51 million, with total stockholders’ equity at $46.75 million. Accounts receivable were recorded at $6.25 million.

Strategic Developments and Outlook

Following the quarter’s close, AmpliTech executed several strategic financial moves to support its growth trajectory. On July 7, 2026, the company terminated its equity distribution agreement with Maxim Group LLC and authorized a stock repurchase program of up to $10 million over the next 24 months. Additionally, on July 22, 2026, the company closed its Series A Rights exercise process, receiving approximately $21.92 million in gross proceeds and $20.12 million in net proceeds after fees.

In July 2026 alone, the company secured more than $6 million in follow-on orders, including nearly $4 million under a previously announced Letter of Intent with a North American mobile network operator. Management stated that it remains focused on scaling revenue, improving operating leverage, and converting customer and technology programs into greater commercial production. The company plans to continue advancing its 5G O-RAN and MMIC programs while improving operational efficiency as its product mix evolves.

What the Numbers Show

The financial results reveal a distinct divergence between operational efficiency and strategic spending priorities. While gross margins nearly quadrupled year-over-year (from 7.8% to 27.9%), indicating successful cost management in production, the net loss widened by approximately 74.5%. This suggests that the operating leverage gained from improved gross margins has been fully absorbed by aggressive investments in R&D, which doubled from $0.66 million to $1.37 million. The subsequent $20.12 million in net proceeds from the Series A Rights exercise provides a substantial capital buffer to sustain these high-growth investments without immediate pressure for profitability.

Financial Performance Table

Metric: Current Quarter (Q2 2026) Prior Year Quarter (Q2 2025) Change
Revenue: $8.07 million N/A (Seq base: $5.35m Q1 2026) +50.9% (Seq)
Gross Profit: $2.25 million $0.86 million +161.2%
Gross Margin: 27.9% 7.8% +20.1 pts
Net Loss: $(3.09) million $(1.77) million -74.5%
R&D Expense: $1.37 million $0.66 million +107.6%
Working Capital: $22.93 million $10.16 million (Dec 31, 2025) +125.6%

Note: Revenue comparison for QoQ is against Q1 2026 ($5.35 million). Prior year revenue is derived from gross profit/margin data.

How long can AmpliTech sustain its current R&D burn rate of $1.37 million per quarter given its cash position and recent capital raise?

What specific milestones must the 5G O-RAN and MMIC programs achieve to justify the doubled R&D expenses and drive future gross margin expansion beyond 27.9%?

Will the newly authorized $10 million stock repurchase program signal management's confidence in undervaluation, or could it constrain liquidity needed for further commercialization investments?

like18
dislike

More News on AmpliTech Group Inc